An Ophthalmic Safety Study in Patients With Breast Cancer

Running, not enrolling

Conditions studied: Ophthalmic Safety in Patients With Breast Cancer

In brief

To assess ophthalmic health in parallel cohorts of patients with breast cancer

Key facts

Study ID
NCT06767462
Run by
AstraZeneca
People needed
160
Starts
2025-03-05
Expected to finish
2027-04-09
Last updated by the study team
2026-06-16

Who can join

Age: 18 and older, up to 130. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.